001     282354
005     20240229155039.0
024 7 _ |a 10.3390/cancers15164067
|2 doi
024 7 _ |a pmid:37627095
|2 pmid
024 7 _ |a pmc:PMC10452452
|2 pmc
024 7 _ |a altmetric:153308540
|2 altmetric
037 _ _ |a DKFZ-2023-01738
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Almanza-Aguilera, Enrique
|0 0000-0002-4805-0774
|b 0
245 _ _ |a Intake of the Total, Classes, and Subclasses of (Poly)Phenols and Risk of Prostate Cancer: A Prospective Analysis of the EPIC Study.
260 _ _ |a Basel
|c 2023
|b MDPI
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1693227223_1865
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Existing epidemiological evidence regarding the potential role of (poly)phenol intake in prostate cancer (PCa) risk is scarce and, in the case of flavonoids, it has been suggested that their intake may increase PCa risk. We investigated the associations between the intake of the total and individual classes and subclasses of (poly)phenols and the risk of PCa, including clinically relevant subtypes. The European Prospective Investigation into Cancer and Nutrition (EPIC) cohort included 131,425 adult men from seven European countries. (Poly)phenol intake at baseline was assessed by combining validated center/country-specific dietary questionnaires and the Phenol-Explorer database. Multivariable-adjusted Cox proportional hazards models were used to estimate the hazard ratios (HR) and 95% confidence intervals (CI). In total, 6939 incident PCa cases (including 3501 low-grade and 710 high-grade, 2446 localized and 1268 advanced, and 914 fatal Pca cases) were identified during a mean follow-up of 14 years. No associations were observed between the total intake of (poly)phenols and the risk of PCa, either overall (HRlog2 = 0.99, 95% CI 0.94-1.04) or according to PCa subtype. Null associations were also found between all classes (phenolic acids, flavonoids, lignans, and stilbenes) and subclasses of (poly)phenol intake and the risk of PCa, overall and according to PCa subtype. The results of the current large prospective cohort study do not support any association between (poly)phenol intake and PCa incidence.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a EPIC
|2 Other
650 _ 7 |a cohort
|2 Other
650 _ 7 |a diet
|2 Other
650 _ 7 |a intake
|2 Other
650 _ 7 |a polyphenols
|2 Other
650 _ 7 |a prostate cancer
|2 Other
700 1 _ |a Guiñón-Fort, Daniel
|b 1
700 1 _ |a Perez-Cornago, Aurora
|b 2
700 1 _ |a Martínez-Huélamo, Miriam
|0 0000-0002-7650-4016
|b 3
700 1 _ |a Andrés-Lacueva, Cristina
|0 0000-0002-8494-4978
|b 4
700 1 _ |a Tjønneland, Anne
|0 0000-0003-4385-2097
|b 5
700 1 _ |a Eriksen, Anne Kirstine
|b 6
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 7
|u dkfz
700 1 _ |a Bajracharya, Rashmita
|0 P:(DE-He78)0b48ce513fe49013263657450a12f870
|b 8
|u dkfz
700 1 _ |a Schulze, Matthias B
|0 0000-0002-0830-5277
|b 9
700 1 _ |a Masala, Giovanna
|0 0000-0002-5758-9069
|b 10
700 1 _ |a Oliverio, Andreina
|0 0000-0002-8624-9186
|b 11
700 1 _ |a Tumino, Rosario
|0 0000-0003-2666-414X
|b 12
700 1 _ |a Manfredi, Luca
|b 13
700 1 _ |a Lasheras, Cristina
|b 14
700 1 _ |a Crous-Bou, Marta
|b 15
700 1 _ |a Sánchez, Maria-José
|0 0000-0003-4817-0757
|b 16
700 1 _ |a Amiano, Pilar
|b 17
700 1 _ |a Colorado-Yohar, Sandra M
|0 0000-0002-6700-0780
|b 18
700 1 _ |a Guevara, Marcela
|0 0000-0001-9242-6364
|b 19
700 1 _ |a Sonestedt, Emily
|0 0000-0002-0747-4562
|b 20
700 1 _ |a Bjartell, Anders
|b 21
700 1 _ |a Thysell, Elin
|b 22
700 1 _ |a Weiderpass, Elisabete
|0 0000-0003-2237-0128
|b 23
700 1 _ |a Aune, Dagfinn
|0 0000-0002-4533-1722
|b 24
700 1 _ |a Aglago, Elom K
|0 0000-0002-0442-3284
|b 25
700 1 _ |a Travis, Ruth C
|b 26
700 1 _ |a Zamora-Ros, Raul
|0 0000-0002-6236-6804
|b 27
773 _ _ |a 10.3390/cancers15164067
|g Vol. 15, no. 16, p. 4067 -
|0 PERI:(DE-600)2527080-1
|n 16
|p 4067
|t Cancers
|v 15
|y 2023
|x 2072-6694
909 C O |o oai:inrepo02.dkfz.de:282354
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)0b48ce513fe49013263657450a12f870
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2023
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2022-01-24T07:56:58Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-30
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2022-11-30
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2022-11-30
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCERS : 2022
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-07-31T16:07:06Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-07-31T16:07:06Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-07-31T16:07:06Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-26
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-26
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CANCERS : 2022
|d 2023-10-26
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21